Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Atara Biotherapeutics (GB:0HIY)
LSE:0HIY
Atara Biotherapeutics (0HIY) Share Price & Analysis
0 Followers
0HIY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.26 - $5.52
Previous Close$1.47
Volume689.00
Average Volume (3M)6.52K
Market Cap
$149.63M
Enterprise Value$47.60M
Total Cash (Recent Filing)$153.79M
Total Debt (Recent Filing)$51.75M
Price to Earnings (P/E)N/A
Beta1.67
Next Earnings
Nov 07, 2023EPS Estimate
-$0.62Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding101,102,152
10 Day Avg. Volume1,002
30 Day Avg. Volume6,524
Standard Deviation0.20
R-Squared0.26
Alpha0.00532
Financial Highlights & Ratios
Price to Book (P/B)20.07
Price to Sales (P/S)2006.72
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.79
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.16
Forecast
1Y Price Target
$20.10Price Target Upside1241.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
Atara Biotherapeutics News
0HIY FAQ
What was Atara Biotherapeutics’s price range in the past 12 months?
Atara Biotherapeutics lowest share price was $1.25 and its highest was $5.52 in the past 12 months.
What is Atara Biotherapeutics’s market cap?
Currently, no data Available
When is Atara Biotherapeutics’s upcoming earnings report date?
Atara Biotherapeutics’s upcoming earnings report date is Nov 07, 2023 which is in 35 days.
How were Atara Biotherapeutics’s earnings last quarter?
Atara Biotherapeutics released its earnings results on Aug 08, 2023. The company reported -$0.68 earnings per share for the quarter, missing the consensus estimate of -$0.656 by -$0.024.
Is Atara Biotherapeutics overvalued?
According to Wall Street analysts Atara Biotherapeutics’s price is currently Undervalued.
Does Atara Biotherapeutics pay dividends?
Atara Biotherapeutics does not currently pay dividends.
What is Atara Biotherapeutics’s EPS estimate?
Atara Biotherapeutics’s EPS estimate is -$0.62.
How many shares outstanding does Atara Biotherapeutics have?
Currently, no data Available
What happened to Atara Biotherapeutics’s price movement after its last earnings report?
Atara Biotherapeutics reported an EPS of -$0.68 in its last earnings report, missing expectations of -$0.656. Following the earnings report the stock price went down -15.285%.
Which hedge fund is a major shareholder of Atara Biotherapeutics?
Among the largest hedge funds holding Atara Biotherapeutics’s share is Baupost Group LLC. It holds Atara Biotherapeutics’s shares valued at 16M.
---
Atara Biotherapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$20.10 (1241.79% Upside)
$20.10 (1241.79% Upside)
Blogger Sentiment
Bullish
GB:0HIY Sentiment 75%
Sector Average 69%
Sector Average 69%
Insider Transactions
Sold Shares
Worth $112.2K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-60.31%
12-Months-Change
Fundamentals
Return on Equity
-229.90%
Trailing 12-Months
Asset Growth
-43.49%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Atara Biotherapeutics
Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA.
---
Atara Biotherapeutics
―
Allogene Therapeutics
―
Crispr Therapeutics AG
―
Editas Medicine
―
Gilead Sciences
―
---